The value of the global pharmaceutical market is in excess of US$ 600 billion. This makes the pharmaceutical sector very vulnerable to corruption and unethical practices. Even though data on financial losses are lacking, Transparency International estimates that, on average, 10 - 25% of public procurement spending, including in the health sector, is lost due to corruption. Regardless of its level, corruption contributes to increased non-availability of medicines and undermines health outcomes as well as public confidence in health care delivery systems...